Catalyst Wire Dossier Catalyst Wire Dossier

BI 113823

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BI 113823, covering 2013-11-01 to 2013-11-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and -Dynamics of Multiple Rising Oral Doses of BI 113823 in Patients Patients With Osteoarthritis of the Knee [Phase 1]

See pricing